Download Financial Reports for Exopharm Limited
Target Market Determination and Prospectus - March 2023
2023 Reports
2022 Reports
2021 Reports
2020 Reports
Quarterly
December 2020 Exopharm Quarterly Activities Report and Appendix 4C
Annual
Exopharm Limited ACN 163 765 991
14/09/20 – Annual Report
2019 Reports
Quarterly
December 2019 Quarterly Activities Report and Appendix 4C
Half-yearly
Annual
Exopharm Limited ACN 163 765 991
17/10/19 – Annual Report
30-08-2019 – Appendix 4E and Annual Financial Report FY 2019
2018 Reports
2017 Reports
2016 Reports
Download Corporate Compliance Documents
Corporate Compliance Documents
31/08/2022 Corporate Governance Statement
26/08/2022 Anti-Bribery and Corruption Policy
26/08/2021 Risk Management Policy
22/04/2021 Board Charter
01/04/2021 Securities Trading Policy
27/12/2019 Whistleblower Policy
01/11/2018 Shareholder Communications Policy
01/11/2018 Audit Policy
01/11/2018 Continuous Disclosure and Market Communications Policy
01/11/2018 Corporate Code of Conduct
01/11/2018 Nomination and Remuneration Policy
Join the Exopharm Mailing List
Join the Exoparm mailing List and receive occasional updates and important information about our work.
